Sarcoma Specialist Consultation: Complete Clinical Guide, Benefits & Recovery

Clinical Overview: Understanding Sarcoma Specialist Consultation

Sarcoma Specialist Consultation represents a cornerstone clinical program at Spica Healthcare — Grover Hospital, Bathinda. Supervised directly by Dr. Deepak Garg (Senior Joint Replacement, Spine & Orthopaedic Oncologist), this evidence-based pathway integrates sub-millimeter surgical precision, advanced intraoperative 3D navigation, ISO Class-100 Laminar Airflow surgical suites, and personalized accelerated rehabilitation to restore function, eliminate pain, and maximize long-term treatment longevity.

In South-Western Punjab and adjoining regions of Haryana and Rajasthan, patients frequently encounter delayed clinical diagnoses or generalized approaches that fail to address anatomical nuances. At Spica Healthcare, every patient undergoes rigorous digital staging, ensuring that surgical interventions or targeted medical therapies are customized to individual biomechanics and oncological requirements.

Clinical Indications: When is Sarcoma Specialist Consultation Recommended?

• Newly diagnosed or suspected bone or soft tissue sarcoma requiring expert staging and treatment planning.

• Patients seeking definitive multidisciplinary review before undergoing biopsy, surgery, or chemotherapy.

• Recurrent sarcomas following prior outside surgery or radiation.

• Pediatric, adolescent, and young adult sarcoma patients requiring specialized limb-preserving care.

Step-by-Step Surgical & Clinical Pathway at Grover Hospital

Step 1: Dual-Specialist Clinical Evaluation

Joint clinical examination by Dr. Deepak Garg (Surgical Oncology) and Dr. Neha Gupta (Medical Oncology).

Step 2: Advanced Imaging & Molecular Workup

3T Contrast MRI, Whole-Body PET-CT, and image-guided Tru-Cut biopsy.

Step 3: Tumor Board Consensus Protocol

Multidisciplinary Tumor Board formulation of neoadjuvant chemotherapy, surgery, and radiation schedule.

Step 4: Limb-Preserving Execution & Follow-Up

Execution of limb salvage surgery and post-operative systemic maintenance protocols.

Director's Signature Innovation: Multidisciplinary Sarcoma Oncology Assessment

Dr. Deepak Garg and Dr. Neha Gupta co-lead the Spica Sarcoma Board, delivering coordinated multidisciplinary care for rare bone and soft tissue sarcomas. By integrating advanced molecular pathology, next-generation genomic sequencing (NGS for fusion genes like EWSR1, SS18-SSX), limb-salvage surgical planning, customized neoadjuvant chemotherapy, and modern intensity-modulated radiation therapy (IMRT), patients achieve high cure rates and long-term limb preservation.

✔ Dual-Director Leadership: Orthopaedic surgical oncology (Dr. Deepak Garg) & medical oncology (Dr. Neha Gupta)

✔ Molecular & NGS Profiling: Identifies specific sarcoma translocations for targeted therapies

✔ Pre-Operative Systemic Staging: High-resolution PET-CT and MRI local compartment workup

✔ Evidence-Based Limb Preservation: 95%+ limb salvage rate through advanced reconstructive surgery

Recovery Timeline & Functional Milestones

Phase 1: Diagnostic Staging & Biopsy (Day 1 – 2)

Comprehensive clinical staging, cross-sectional imaging review, and core biopsy scheduling.

Phase 2: Molecular Profiling (Day 3 – 5)

Histopathology, IHC staining, and molecular fusion gene NGS panel confirmation.

Phase 3: Multidisciplinary Treatment Roadmap (Day 6 – 7)

Spica Multidisciplinary Tumor Board roadmap and initiation of customized treatment.

Frequently Asked Clinical Questions (FAQs)

Why do sarcomas require specialized multidisciplinary treatment?

Sarcomas are rare, aggressive cancers that behave very differently from common epithelial cancers (like carcinomas). Treatment requires a coordinated multidisciplinary team of orthopaedic oncologists, medical oncologists, and specialized musculoskeletal pathologists to prevent amputation and optimize cure.

What is the long-term survival outlook for localized sarcomas?

Through standardized multimodal treatment (neoadjuvant chemotherapy + computer-navigated limb salvage surgery + targeted radiation), localized bone and soft tissue sarcomas have high 5-year survival rates ranging between 70% to 85%+.

Is Sarcoma Care covered under Ayushman Bharat?

Yes, sarcoma consultations, molecular diagnostic reviews, and inpatient care at Grover Hospital Bathinda are covered under PM-JAY Ayushman Bharat and 30+ private insurance TPAs.

100% Cashless Insurance & PM-JAY Ayushman Bharat Empanelment

At Spica Healthcare — Grover Hospital Bathinda, Sarcoma Specialist Consultation is fully covered under the Government of India's PM-JAY Ayushman Bharat scheme and over 30+ leading private insurance TPAs. Our on-campus insurance coordinator handles all pre-authorization documentation directly with your insurance company, eliminating financial delays. Families can also share digital DICOM CDs and biopsy reports via WhatsApp (+91 95013 73003) for an urgent surgical review.